Table 1 Information of lumbar fenestration and nusinersen administration in SMA patients with spinal fixation
No | Gender | Age of surgery (y) | Clinical classification | Fusion range | Level of fenestration | Times of injection | Guiding methods (ultrasound/X-ray/CT) | Interval between surgery and first injection (m) | Types of complications | Times of complications |
|---|---|---|---|---|---|---|---|---|---|---|
1 | Male | 26 | II | T3-pelvis | L3/L4 | 5 | Ultrasound | 22 | N | 0 |
2 | Female | 17 | II | T2-pelvis | L3/L4 | 0 | – | – | – | – |
3 | Female | 13 | III | T3-pelvis | L3/L4 | 0 | – | – | – | – |
4 | Female | 12 | II | T3-pelvis | L2/L3 | 9 | Ultrasound | 3 | N | 0 |
5 | Male | 12 | II | T2-pelvis | L2/L3 | 0 | – | – | – | – |
6 | Female | 11 | II | T3-pelvis | L2/L3 | 6 | Ultrasound | 11 | Headache | 3 |
7 | Male | 18 | III | T3-pelvis | L2/L3 | 5 | Ultrasound | 13 | Headache | 2 |
8 | Male | 28 | II | T6–L5 | L3/L4 | 4 | Ultrasound | 18 | N | 0 |
9 | Female | 14 | II | T3-pelvis | L3/L4 | 5 | Ultrasound | 12 | N | 0 |
10 | Male | 15 | II | T3-pelvis | L2/L3 | 4 | Ultrasound | 15 | Headache and nausea | 2 |
11 | Male | 11 | II | T4–L5 | L2/L3 | 6 | Ultrasound | 3 | N | 0 |
12 | Female | 20 | III | T4-pelvis | L3/L4 | 6 | Ultrasound | 5 | Vertigo | 1 |
13 | Female | 20 | II | T3-pelvis | L3/L4 | 0 | – | – | – | – |